10-70095660-T-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018649.3(MACROH2A2):āc.595T>Gā(p.Leu199Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000224 in 1,527,588 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_018649.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MACROH2A2 | NM_018649.3 | c.595T>G | p.Leu199Val | missense_variant | 6/9 | ENST00000373255.9 | NP_061119.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MACROH2A2 | ENST00000373255.9 | c.595T>G | p.Leu199Val | missense_variant | 6/9 | 1 | NM_018649.3 | ENSP00000362352.3 |
Frequencies
GnomAD3 genomes AF: 0.000230 AC: 35AN: 152242Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000999 AC: 25AN: 250300Hom.: 0 AF XY: 0.0000813 AC XY: 11AN XY: 135232
GnomAD4 exome AF: 0.000223 AC: 307AN: 1375346Hom.: 0 Cov.: 23 AF XY: 0.000210 AC XY: 145AN XY: 689044
GnomAD4 genome AF: 0.000230 AC: 35AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.000202 AC XY: 15AN XY: 74384
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 18, 2023 | The c.595T>G (p.L199V) alteration is located in exon 6 (coding exon 5) of the H2AFY2 gene. This alteration results from a T to G substitution at nucleotide position 595, causing the leucine (L) at amino acid position 199 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at